AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and Chief Financial Analysts: Jayson T. Bedford — Raymond James — Analyst Matthew I. Mishan — KeyBanc Capital Markets — Analyst Bill J. Plovanic — Canaccord Genuity — Analyst _________ To read the full earnings call transcript, click here
“AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and Chief Financial Analysts: Jayson T. Bedford — Raymond James — Analyst Matthew I. Mishan — KeyBanc Capital Markets — Analyst Bill J. Plovanic — Canaccord Genuity — Analyst _________ To read the full earnings call transcript, click here
· January 8, 2021
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021
Jim Clemmer — President and Chief Executive
Stephen A. Trowbridge — Executive Vice President and Chief Financial
Jayson T. Bedford — Raymond James — Analyst
Matthew I. Mishan — KeyBanc Capital Markets — Analyst
Bill J. Plovanic — Canaccord Genuity — Analyst
_________
To read the full earnings call transcript, click here
